PHENOXYBENZAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phenoxybenzamine, and what generic alternatives are available?
Phenoxybenzamine is a drug marketed by Amneal, Aurobindo Pharma, Hikma, Novitium Pharma, Ph Health, and Rising. and is included in six NDAs.
The generic ingredient in PHENOXYBENZAMINE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenoxybenzamine
A generic version of PHENOXYBENZAMINE was approved as phenoxybenzamine hydrochloride by PH HEALTH on January 24th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHENOXYBENZAMINE?
- What are the global sales for PHENOXYBENZAMINE?
- What is Average Wholesale Price for PHENOXYBENZAMINE?
Summary for PHENOXYBENZAMINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for PHENOXYBENZAMINE |
| DailyMed Link: | PHENOXYBENZAMINE at DailyMed |


